Cargando…

Exploring miRNA-Associated Signatures with Diagnostic Relevance in Glioblastoma Multiforme and Breast Cancer Patients

The growing attention that non-coding RNAs have attracted in the field of cancer research in recent years is undeniable. Whether investigated as prospective therapeutic targets or prognostic indicators or diagnostic biomarkers, the clinical relevance of these molecules is starting to emerge. In addi...

Descripción completa

Detalles Bibliográficos
Autores principales:	LeBlanc, Véronique C., Morin, Pier Jr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555080/ https://www.ncbi.nlm.nih.gov/pubmed/26287251 http://dx.doi.org/10.3390/jcm4081612

Ejemplares similares

The Role of miRNA for the Treatment of MGMT Unmethylated Glioblastoma Multiforme
por: Kirstein, Anna, et al.
Publicado: (2020)

A 3-miRNA Signature Enables Risk Stratification in Glioblastoma Multiforme Patients with Different Clinical Outcomes
por: Bafiti, Vivi, et al.
Publicado: (2022)

Involvement of miRNAs in the Differentiation of Human Glioblastoma Multiforme Stem-Like Cells
por: Aldaz, Beatriz, et al.
Publicado: (2013)

microRNAs (miRNAs) in Glioblastoma Multiforme (GBM)—Recent Literature Review
por: Makowska, Marianna, et al.
Publicado: (2023)

Network Signatures of Survival in Glioblastoma Multiforme
por: Patel, Vishal N., et al.
Publicado: (2013)

In silico analysis identified miRNA-based therapeutic agents against glioblastoma multiforme
por: Xiong, Dan-Dan, et al.
Publicado: (2019)

Construction of Potential Glioblastoma Multiforme-Related miRNA-mRNA Regulatory Network
por: Lou, Weiyang, et al.
Publicado: (2019)

Exploring VEGF-Linked Pathways: Investigating Multiple miRNAs for Their Therapeutic Potential in Angiogenesis Targets and as Biomarkers in Recurrent Glioblastoma Multiforme
por: Hadizadeh, Morteza, et al.
Publicado: (2022)

A 6-Gene Risk Signature Predicts Survival of Glioblastoma Multiforme
por: Zhao, Jingwei, et al.
Publicado: (2019)

Longevity-Related Gene Transcriptomic Signature in Glioblastoma Multiforme
por: Fawzy, Manal S., et al.
Publicado: (2018)

Prognostic and Predictive Value of an Immunoscore Signature in Glioblastoma Multiform
por: Tang, Xiangjun, et al.
Publicado: (2020)

miR-340 suppresses glioblastoma multiforme
por: Huang, Daquan, et al.
Publicado: (2015)

Prognostic Relevance of Cytochrome c Oxidase in Primary Glioblastoma Multiforme
por: Griguer, Corinne E., et al.
Publicado: (2013)

Genomic Analysis of Glioblastoma Multiforme Reveals a Key Transcription Factor Signature Relevant to Prognosis and the Immune Processes
por: Li, Zhen-Hang, et al.
Publicado: (2021)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Exploring the role of Nrf2 signaling in glioblastoma multiforme
por: Awuah, Wireko Andrew, et al.
Publicado: (2022)

A 4-miRNA signature to predict survival in glioblastomas
por: Hermansen, Simon K., et al.
Publicado: (2017)

Chromosomal Instability and Phosphoinositide Pathway Gene Signatures in Glioblastoma Multiforme
por: Waugh, Mark G.
Publicado: (2014)

A 4-miRNA signature predicts the therapeutic outcome of glioblastoma
por: Niyazi, Maximilian, et al.
Publicado: (2016)

Identifying the miRNA Signature Association with Aging-Related Senescence in Glioblastoma
por: Gnanavel, Mutharasu, et al.
Publicado: (2021)

A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme
por: Gao, Ming, et al.
Publicado: (2021)

Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme
por: Yu, Ziye, et al.
Publicado: (2022)

Glioblastoma and MiRNAs
por: Ahmed, Swalih P., et al.
Publicado: (2021)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

MiR-181 Family Modulates Osteopontin in Glioblastoma Multiforme
por: Marisetty, Anantha, et al.
Publicado: (2020)

A-to-I editing in human miRNAs is enriched in seed sequence, influenced by sequence contexts and significantly hypoedited in glioblastoma multiforme
por: Paul, Deepanjan, et al.
Publicado: (2017)

An Integrated mRNA and microRNA Expression Signature for Glioblastoma Multiforme Prognosis
por: Xiong, Jie, et al.
Publicado: (2014)

Analysis of microarray data for identification of key microRNA signatures in glioblastoma multiforme
por: Shaji, Sanu K., et al.
Publicado: (2019)

Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme
por: Yang, Ji’an, et al.
Publicado: (2020)

Integration of RNA-Seq and proteomics data identifies glioblastoma multiforme surfaceome signature
por: Syafruddin, Saiful Effendi, et al.
Publicado: (2021)

Identification of T‐cell exhaustion‐related gene signature for predicting prognosis in glioblastoma multiforme
por: Liu, Yue‐hui, et al.
Publicado: (2023)

Tectal plate glioblastoma multiforme
por: Nemer, Michael D., et al.
Publicado: (2011)

Bilateral cystic glioblastoma multiforme
por: Kumar, Sushil, et al.
Publicado: (2013)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

Atypical Presentation of Glioblastoma Multiforme
por: Al-Janabi, Wissam, et al.
Publicado: (2018)

Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)

The complement system in glioblastoma multiforme
por: Bouwens van der Vlis, T. A. M., et al.
Publicado: (2018)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Survival Analysis of Glioblastoma Multiforme
por: Witthayanuwat, Supapan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1cj190cqd7gi6stobfia6t7f0t